Medtronic (MDT) just announced the launch of a new clinical study in the U.S. that will test its Hugo robotic-assisted ...

Medtronic’s stock sat on the discount rack for years. Then, in August, a well-known activist investor finally took the bait, ...

Medtronic announced full distribution in the United States of Contego Medical’s Neuroguard integrated embolic protection ( ...

Medtronic plc (NYSE:MDT) is included among the Top 15 Growth Stocks for Long-Term Investors. Medtronic plc (NYSE:MDT) st⁠ands ...

Medtronic’s MDT acquisition of Covidien has produced a combined company that’s a force to be reckoned with in medical technology. Pairing Medtronic’s diversified product portfolio aimed at a wide ...

Medtronic (NYSE:MDT) strengthens its healthcare offerings. Key sectors of Medtronic show growth. S&P 500 futures reflects ...

The experiences of one surgeon are raising questions about the costs and risks of a Medtronic Inc. (MDT) bone-growth product, threatening to pressure further the company's spinal business. According ...

Medtronic has a vast and diversified portfolio of medical devices. It benefits from pricing power thanks to its patented and ...

Fridley-based Medtronic, Inc., recently received a letter from two U.S. senators requesting information about the use of the company's Infuse bone-growth product and payments it made to clinical ...

An unresolved warning letter from the Food and Drug Administration continues to cause trouble for the heart device division at Fridley-based Medtronic. After releasing second-quarter results earlier ...

Medtronic is buying Covidien in a tax-friendly move, but here are three other reasons the deal makes sense. The two companies have big and growing businesses that complement one another, too. Here are ...